- Home
- BTAI vs SYPR Comparison
BTAI vs SYPR Comparison
Compare BTAI & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- SYPR
- Stock Information
- Founded
- BTAI 2017
- SYPR 1997
- Country
- BTAI United States
- SYPR United States
- Employees
- BTAI N/A
- SYPR N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- SYPR Industrial Machinery/Components
- Sector
- BTAI Health Care
- SYPR Industrials
- Exchange
- BTAI Nasdaq
- SYPR Nasdaq
- Market Cap
- BTAI 22.6M
- SYPR 37.4M
- IPO Year
- BTAI 2018
- SYPR 1994
- Fundamental
- Price
- BTAI $0.57
- SYPR $1.56
- Analyst Decision
- BTAI Strong Buy
- SYPR
- Analyst Count
- BTAI 4
- SYPR 0
- Target Price
- BTAI $5.50
- SYPR N/A
- AVG Volume (30 Days)
- BTAI 461.3K
- SYPR 9.6K
- Earning Date
- BTAI 11-12-2024
- SYPR 11-13-2024
- Dividend Yield
- BTAI N/A
- SYPR N/A
- EPS Growth
- BTAI N/A
- SYPR N/A
- EPS
- BTAI N/A
- SYPR N/A
- Revenue
- BTAI $2,403,000.00
- SYPR $139,390,000.00
- Revenue This Year
- BTAI $253.55
- SYPR N/A
- Revenue Next Year
- BTAI $104.78
- SYPR N/A
- P/E Ratio
- BTAI N/A
- SYPR N/A
- Revenue Growth
- BTAI 131.50
- SYPR 13.49
- 52 Week Low
- BTAI $0.51
- SYPR $1.27
- 52 Week High
- BTAI $5.62
- SYPR $2.30
- Technical
- Relative Strength Index (RSI)
- BTAI 47.47
- SYPR 46.23
- Support Level
- BTAI $0.51
- SYPR $1.49
- Resistance Level
- BTAI $0.59
- SYPR $1.65
- Average True Range (ATR)
- BTAI 0.04
- SYPR 0.04
- MACD
- BTAI 0.01
- SYPR -0.01
- Stochastic Oscillator
- BTAI 47.15
- SYPR 40.62
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sale of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.